Pure Global

PRostate Olaparib Real World Evidence Study - Trial NCT06031805

Access comprehensive clinical trial information for NCT06031805 through Pure Global AI's free database. This phase not specified trial is sponsored by AstraZeneca and is currently Recruiting. The study focuses on Metastatic Castration-resistant Prostate Cancer. Target enrollment is 300 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06031805
Recruiting
Trial Details
ClinicalTrials.gov • NCT06031805
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
PRostate Olaparib Real World Evidence Study
a French Observational Prospective Multicenter Study of Adult Patients Treated in the Real-life Setting With Olaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer

Study Focus

Observational

Sponsor & Location

AstraZeneca

Amiens,Angers Cedex 02,Angers Cedex 9,Antony,Argenteuil,Avignon,Bayonne,Besancon,Bordeaux,Bordeaux,Caen,Cagnes-sur-mer,Challes Les Eaux,Chambray Les Tours,Champigny Sur Marne,Clermont-ferrand Cedex 1,, France

Timeline & Enrollment

N/A

Oct 11, 2023

Oct 13, 2028

300 participants

Primary Outcome

Time to treatment discontinuation (TTD)

Summary

This French non-interventional prospective multicenter cohort study is conducted to study the
 added value of olaparib in the treatment of patients with mCRPC in the real world setting in
 terms of treatment sequencing, effectiveness, safety and BRCA testing patterns and thus
 inform future clinical practice.

ICD-10 Classifications

Malignant neoplasm of prostate
Hyperplasia of prostate
Carcinoma in situ: Prostate
Special screening examination for neoplasm of prostate
Dysplasia of prostate

Data Source

ClinicalTrials.gov

NCT06031805

Non-Device Trial